ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
The Second Affiliated Hospital of Zhejiang University School of Medicine at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
The Second Affiliated Hospital of Zhejiang University School of Medicine takes part in 10 sessions at ESMO 2026 in Madrid. Its work spans gastrointestinal, breast and lung cancers, with additional research in rare cancers and biomarkers. Specific topics include colorectal cancer screening tests, treatments for metastatic colorectal cancer and surgery for colon cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
SA The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, China | |
Teaching hospital of Zhejiang University School of Medicine in Hangzhou, China. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 ASCL1 subtype predominance in brain metastases of small cell lung cancer Lung & thoracic cancers Poster Mon Oct 26 12:00–12:45 Cadonilimab plus anlotinib in patients with advanced soft tissue sarcoma after failure of standard first-line therapy: A prospective phase II trial Sarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 HER2 overexpression after EGFR-TKI resistance in EGFR-mutant NSCLC: Clinical correlates and ERBB family co-activation Lung & thoracic cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Phase II study of first-line envafolimab in combination with liposomal doxorubicin and ifosfamide for advanced soft tissue sarcoma Sarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 Updated survival outcomes and CD28+ICOS+CD4+ T cells as a predictive biomarker from the randomized phase II neoSCORE trial of neoadjuvant chemoimmunotherapy in resectable NSCLC Lung & thoracic cancersBiomarkers & precision oncology |
Find decision makers at The Second Affiliated Hospital of Zhejiang University School of Medicine
Tell us what you sell and we’ll find the people at The Second Affiliated Hospital of Zhejiang University School of Medicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction